ORBIMED ADVISORS LLC 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:25 pm Sale | 2022-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | ORBIMED ADVISORS LLC | 80,421 2.400% | -86,369 (-51.78%) | Filing |
| 2022-02-11 4:26 pm Purchase | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | ORBIMED ADVISORS LLC | 166,790 5.100% | 64,720 (+63.41%) | Filing |
| 2021-02-12 4:49 pm Sale | 2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | ORBIMED ADVISORS LLC | 102,070 4.020% | -34,000 (-24.99%) | Filing |